Funder
CIHR
Genome Canada (CA) and Genome Quebec
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health(social science),Issues, ethics and legal aspects
Reference37 articles.
1. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74.
2. Hegde M, Bale S, Bayrak-Toydemir P, Gibson J, Jeng LJ, Joseph L, et al. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. J Mol Diagn. 2015;17:107–17.
3. The Royal College of Pathologists of Australia: Implementation of Massively Parallel Sequencing in Diagnostic Medical Genetic Testing. 2014
https://www.rcpa.edu.au/getattachment/7d264a73-938f-45b5-912f-272872661aaa/Massively-Parallel-Sequencing-Implementation
. Accessed June 12, 2017.
4. Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the clinical, research, and direct-to-consumer contexts. Report of the presidential Commission for the Study of bioethical issues. Washington, DC: Presidential Commission for the Study of Bioethical Issues. December 2013.
5. Middleton A, Patch C, Wiggins J, Barnes K, Crawford G, Benjamin C, Bruce A. Position statement on 392 opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland). Eur J Hum Genetics. 2014;22:955–6.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献